In vitro deposition properties of nebulized formoterol fumarate: effect of nebulization time, airflow, volume of fill and nebulizer type

References

• Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127:335-71
   PubMed Web of Science ®Google Scholar
• Torres A Jr, Anders M, Anderson P, et al. Efficacy of metered-dose inhaler administration of albuterol in intubated infants. Chest 1997;112:484-90
   PubMed Web of Science ®Google Scholar
• Gay PC, Patel HG, Nelson SB, et al. Metered dose inhalers for bronchodilator delivery in intubated, mechanically ventilated patients. Chest 1991;99:66-71
   PubMed Web of Science ®Google Scholar
• Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbation of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001;134:600-20
   PubMed Web of Science ®Google Scholar
• O’Donohue WJ Jr. Guidelines for the use of nebulizers in the home and at domiciliary sites: report of a consensus conference. Chest 1996;109:814-20
   PubMed Web of Science ®Google Scholar
• Boe J, Dennis JH, O’Driscoll BR, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J 2001;18:228-42
   PubMed Web of Science ®Google Scholar
• Hess D, Fisher D, Williams P, et al. Medication nebulizer performance – effects of diluent volume, nebulizer flow and nebulizer brand. Chest 1996;110:498-505
   PubMed Web of Science ®Google Scholar
• Coates AL, MacNeish CF, Meisner D, et al. The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols. Chest 1997;111:1206-12
   PubMed Web of Science ®Google Scholar
• Hardy JG, Newman SP, Knock M. Lung deposition from four nebulizers. Respir Med 1993;87:461-5
   PubMed Web of Science ®Google Scholar
• Clay MM, Pavia D, Newman SP, et al. Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 1983;38:755-9
   PubMed Web of Science ®Google Scholar
• Weber A, Morlin GL, Cohen M, et al. Effect of nebulizer type and antibiotic concentration on device performance. Pediatric Pulmonol 1997;23:249-60
   PubMed Web of Science ®Google Scholar
• Newman SP, Pellow PG, Clay MM, et al. Evaluation of jet nebulizers for use with gentamicin solution. Thorax 1985; 40:671-6
   PubMed Web of Science ®Google Scholar
• MacNeish CF, Meisner D, Thibert R, et al. A comparison of pulmonary availability between Ventolin (albuterol) nebules and Ventolin (albuterol) respiration solution. Chest 1997; 111:204-8
   PubMed Web of Science ®Google Scholar
• Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003;56: 588-99
   Google Scholar
• Phipps PR, Gonda I. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration. Chest 1990;97:1327-32
   Google Scholar
• Dahlback M, Nerbrink O, Arborelius M, et al. Output characteristics from three medical nebulizers. J Aerosol Sci 1986; 17:563-4
   Web of Science ®Google Scholar
• O’Driscoll BR, Taylor RJ, Horsley MG, et al. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;1:1418-20
   PubMed Web of Science ®Google Scholar
• Berger WE, Nadel JA. Efficacy and safety of formoterol for the treatment of chronic obstructive pulmonary disease. Respir Med 2008;102:173-88
   PubMed Web of Science ®Google Scholar
• D’Urzo AD, De Salvo MC, Ramirez-Rivera A, et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium: a 3-week, randomized, double-blind, within-patient, multicenter study. Chest 2001;119: 1347-56
   PubMed Web of Science ®Google Scholar
• Guidance for industry: Analytical procedures and method validation -- chemistry, manufacturing, and controls documentation. FDA/Center for Drug Evaluation and Research, 2000. Available at: www.fda.gcov/cder/guidance/index.htm chemistry [Last accessed 6 October 2008]
   Google Scholar
• Akapo S, Gupta J, Martinez E, et al. The compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacother 2008;42: 1416-24
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Basbaum CB, Nadel JA, et al. Localization of β-receptors in mammalian lung by light microscopic autoradiography. Nature 1982;229:444-7
   Google Scholar
• Barnes PJ, Basbaum CB, Nadel JA. Autoradiographic localization of autonomic receptors in airway smooth muscle. Am Rev Respir Dis 1983;127:758-62
   PubMed Web of Science ®Google Scholar
• Mak JCW, Barnes PJ. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 1990;141:1559-68
   PubMed Web of Science ®Google Scholar
• Donohue JF. Combination therapy for chronic obstructive pulmonary disease: clinical aspects. Proc Am Thorac Soc 2005;2:272-81
   PubMedGoogle Scholar
• Chen AM, Bollmeier SG, Finnegan PM. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Ann Pharmacother 2008;42:1832-42
   PubMed Web of Science ®Google Scholar
• Zanen P, Go LT, Lammers JW. Optimal particle size for β2 agonist and anticholinergic aerosols in patients with severe airflow obstruction. Thorax 1996;51:977-80
   PubMed Web of Science ®Google Scholar
• Ho SL, Kwong WT, O’Drowsky L, et al. Evaluation of four breath-enhance nebulizers for home use. J Aerosol Med 2001;14:467-75
   PubMedGoogle Scholar
• Newman SP, Clarke SW. Therapeutic aerosols: I. Physical and practical considerations. Thorax 1983;38:881-6
   PubMed Web of Science ®Google Scholar
• Malone RA, Hollie MC, Glynn-Barnhart A, et al. Optimal duration of nebulized albuterol therapy. Chest 1993;104:1114-18
   PubMed Web of Science ®Google Scholar
• Mercer TT. Production of therapeutic aerosols: principles and techniques. Chest 1981;80:813-18
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ahuja A, Irvin CM, et al. Medical nebulizer performance: effects of cascade impactor temperature. Respir Care 2005;50:1077-82
   PubMedGoogle Scholar
• Reviewer guidance for nebulizers, metered dose inhalers, spacers and actuator. FDA/Center for devices and Radiological Health, 1993. Available at: www.fda.gov/cdrh/ode/784.html [Last accessed 6 October 2008]
   Google Scholar